Abstract OBJECTIVE: To examine plasma adiponectin (ADPN) and tumor necrosis factor-alpha (TNF-α) levels and their correlation in children with obesity in order to investigate the roles of both in the development of childhood obesity. METHODS: One hundred and forty-seven children with obesity and 118 normal children who were randomly sampled from five primary schools from the Kaifu District in Changsha were enrolled. Physical shape indexes, including height, weight, waist circumference, hip circumference, and waist to hip ratio (WHR) were measured. Body mass index (BMI) was calculated. Blood pressure was measured. Percentage of body fat (%BF) was measured with dual energy X-ray absorptiometry. Plasmal levels of ADPN and TNF-α were detected using ABC-ELISA. Blood concentrations of triglycerides (TG), total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C) and low density lipoprotein-cholesterol (LDL-C) were measured by automatic biochemistry analyzer. Fasting blood glucose level was measured by glucose oxidase method. Fasting blood insulin level was assayed by radioimmunity. Homeostasis model assessment for insulin resistance (HOMA-IR) was performed. RESULTS: Plasma ADPN levels in obese children significantly decreased compared with those in normal children (8.12±2.54 mg/L vs 12.22±4.68 mg/L; P<0.05), and had a negative correlation with plasma TNF-α levels, BMI, WHR and HOMA-IR (P<0.01), and with %BF, fasting insulin, systolic blood pressure and TG (P<0.05). Plasma TNF-α levels in obese children significantly increased compared to normal children (171.38±34.33 ng/L vs 91.07±21.60 ng/L; P<0.01) and positively correlated with BMI, WHR, %BF, fasting insulin, HOMA-IR, TG and systolic blood pressure (P<0.01), and negatively with HDL (P<0.05). Multiple stepwise regression analysis showed that ADPN, BMI and TNF-α were main influential factors for %BF (R2=0.926, P<0.01). There was a significant interaction between ADPN and TNF-α (P<0.05). CONCLUSIONS: Plasma ADPN levels decreased and plasma TNF-α levels increased in children with obesity and both were main influential factors for %BF in children. There was an interaction between ADPN and TNF-α, suggesting that they both participate in the development of childhood obesity. ［Chin J Contemp Pediatr, 2009, 11 (1):47-50］
YAN Wei-Jian,WU Jing,MO Juan et al. Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity[J]. 中国当代儿科杂志, 2009, 11(01): 47-50.
YAN Wei-Jian,WU Jing,MO Juan et al. Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity[J]. CJCP, 2009, 11(01): 47-50.
［4］Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataanni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia ［J］. J Clin Endocrinol Metab, 2002, 87(10):4652-4656.
［5］Halle M, Korsten-Reck U, Wolfarth B, Berg A. Low-grade systemic inflammation in overweight children: impact of physical fitness［J］. Exerc Immunol Rev, 2004, 10:66-74.
［6］Zhao T, Hou M, Xia M, Wang Q, Zhu H, Xiao Y, et al. Globular adiponectin decreases leptin-induced tumor necrosis factor-alpha expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways［J］. Cell Immunol, 2005, 238 (1):19-30.
［7］Hector J, Schwarzloh B, Goehring J, Strate TG, Hess UF, Deu-retzbacher G, et al. TNF-alpha alters visfatin and adiponectin levels in human fat［J］. Horm Metab Res, 2007, 39(4):250-255.
［8］Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expressi-on from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression［J］. Diabetes, 2003, 52(7):1779-1785.
［10］Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children［J］. J Clin Endocrinol Metab, 2004, 89(8):3790-3794.
［11］Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Pla-sma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans［J］. Diabetes, 2002, 51(6):1884-1888．
［12］Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activatingAMP-activated protein kinase［J］．Nature Med, 2002, 8(11):1288-1295．
［13］Moon YS, Kim DH, Song DK. Serum tumor necrosis factor alpha levels and components of the metabolic syndrome in obese adolescents［J］. Metabolism, 2004, 53(7): 863-867.
［15］Prins JB, Niesler CU. Tumor necrosis factor-alpha induces apoptosis of human adipose cells［J］. Diabetes, 1997, 46(12):1939-1944.
［16］Cawthorn WP, Sethi JK. TNF-α and adipocyte biology［J］. FEBS Lett, 2007, 51(11):1-15.
［17］Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expressi-on and plasma concentrations of adiponectin, an adipose-derived protein［J］. Diabetes, 2001, 50(9): 2094-2099.
